BioVirtus is a full-service early phase clinical sites' network located in Poland (CEE). BioVirtus provides international pharmaceutical and biotech customers with comprehensive, cost effective, and FDA/EMA compliant early clinical studies. Services include: study design and medical writing, recruitment of subjects and patients, clinical conduct in dedicated site located near Warsaw (45 beds), electronic data capture, data processing and reporting. BioVirtus expertise include: > First-in-Man > Phase I/II healthy & patients, various indications > Special populations > Proof-of-Concept > Bioequivalence > Bioavailability > Food effect > PK/PD studies > Biosimilars > Therapeutic equivalence > Nicotine risk evaluation & smoking-cessation studies. www.biovirtus.eu
View Top Employees from BioVirtus Research SiteWebsite | http://biovirtus.eu |
Revenue | $8.7 million |
Employees | 11 (6 on RocketReach) |
Founded | 2012 |
Address | 5-2 Ul. A. Locci, Warsaw, Masovian Voivodeship 02-928, PL |
Phone | +48 22 101 07 54 |
Fax | +48 22 101 07 56 |
Technologies |
HTML,
PHP,
Google Analytics
+5 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Medical Testing & Clinical Laboratories, Clinical Research, Healthcare, Bioequivalence, Biosimilars, Early Phase, Oncology, Tobacco Exposure & Smoking Cessation Studies, Studies With Healthy Volunteers, Studies With Patients & Special Populations |
SIC | SIC Code 80 Companies, SIC Code 807 Companies |
NAICS | NAICS Code 62 Companies, NAICS Code 6215 Companies, NAICS Code 62151 Companies, NAICS Code 621 Companies |
Looking for a particular BioVirtus Research Site employee's phone or email?
The BioVirtus Research Site annual revenue was $8.7 million in 2024.
6 people are employed at BioVirtus Research Site.
BioVirtus Research Site is based in Warsaw, Masovian Voivodeship.
The NAICS codes for BioVirtus Research Site are [62, 6215, 62151, 621].
The SIC codes for BioVirtus Research Site are [80, 807].